Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Complement System01:27

Complement System

2.7K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
2.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

652
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
652
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Selectins01:25

Selectins

3.4K
Cell adhesion is  an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.4K
Antimicrobial Proteins01:23

Antimicrobial Proteins

4.7K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
4.7K
Complementation Tests00:49

Complementation Tests

5.1K
A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathologic evaluation of pig kidney and heart xenografts: 2024 recommendations from the Banff Xenotransplantation Pathology Working Group.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Total Versus Ionized Calcium: Valid Index of Calcium Status in Critically Ill Patients.

Archives of pathology & laboratory medicine·2026
Same author

Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN.

The New England journal of medicine·2025
Same author

Prevalence and trends of transfusion transmitted infections among blood donors in a tertiary care hospital of Assam.

Scientific reports·2025
Same author

Moving beyond jargon: Operationalising gender-transformative approaches to end harmful practices against adolescents.

Global public health·2025
Same author

Pegcetacoplan for the treatment of geographic atrophy due to age-related macular degeneration: a plain language summary of OAKS and DERBY clinical studies.

Immunotherapy·2025
Same journal

Immunogenicity and protective potential of a mucosal protein-only vaccine candidate for tuberculosis.

Frontiers in immunology·2026
Same journal

The role of mitochondrial proteases in inflammation and immunity.

Frontiers in immunology·2026
Same journal

Long term survival in three pancreatic cancer patients following Whipple's procedure and allogeneic hematopoietic cell transplantation.

Frontiers in immunology·2026
Same journal

Innate immune circuits in acute lung injury: macrophage plasticity, ILC crosstalk, and tissue repair failure.

Frontiers in immunology·2026
Same journal

Next-generation CAR-T engineering for colorectal cancer: integrating targets, tumor microenvironment barriers, and emerging strategies.

Frontiers in immunology·2026
Same journal

Comparative assessment of tissue cross-reactivity and pharmacokinetic half-life of malaria monoclonal antibodies.

Frontiers in immunology·2026
See all related articles

Related Experiment Video

Updated: Sep 4, 2025

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
06:54

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion

Published on: June 15, 2019

6.1K

Inside-Out of Complement in Cancer.

Martin Kolev1, Madhumita Das1, Monica Gerber2

  • 1Discovery, Apellis Pharmaceuticals, Waltham, MA, United States.

Frontiers in Immunology
|July 21, 2022
PubMed
Summary
This summary is machine-generated.

Complement plays a dual role in cancer, potentially accelerating tumor growth while also influencing anti-tumor immunity. Understanding its intracellular functions is key for developing new cancer therapies and biomarkers.

Keywords:
biomarkerscancercomplosomeextracellular complementintracellular complementtherapytumor microenvironment

More Related Videos

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.8K
Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
12:19

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

1.3K

Related Experiment Videos

Last Updated: Sep 4, 2025

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
06:54

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion

Published on: June 15, 2019

6.1K
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.8K
Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
12:19

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

1.3K

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • The complement system, crucial for microbial defense, is increasingly recognized for its complex role in cancer.
  • While extracellular complement activation is well-studied in cancer, the significance of intracellular complement pathways remains largely unexplored.
  • Emerging evidence suggests complement can paradoxically promote cancer progression by suppressing anti-tumor immunity.

Purpose of the Study:

  • To review the multifaceted functions of the complement system in cancer.
  • To explore the implications of both extracellular and intracellular complement activation in malignancy.
  • To discuss the potential of complement as a therapeutic target and biomarker in cancer treatment.

Main Methods:

  • Literature review of recent studies on complement in cancer.
  • Analysis of extracellular and intracellular complement activation pathways.
  • Examination of complement protein distribution in tumor microenvironments and periphery.

Main Results:

  • Complement can accelerate cancer progression, partly by suppressing anti-tumor immunity via host cell regulation within the tumor microenvironment.
  • Intracellular complement activation, termed the 'complosome,' is vital for immune cell survival and T cell activation, suggesting a role in tumor cell survival and anti-tumor responses.
  • Complement proteins exhibit distinct spatial distributions in tumors and peripheral tissues, influencing their functions.

Conclusions:

  • The complement system's role in cancer is complex, involving both pro-tumor and anti-tumor effects.
  • Intracellular complement activation presents a novel area of investigation with potential implications for tumor cell survival and anti-tumor immunity.
  • Further research into complement pathways, including intracellular activation, is warranted to explore its potential as a biomarker and therapeutic target in oncology.